InsidersTradesSigma
Track the Kite Pharma, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 16 February 2016 (Cession). Among the most active insiders: Sproule Rizwana F. All data is openly available.
46
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
36 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Kite Pharma, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 February 2016
Declarations46 total
18,750 sharesCommon StockSEC:0001209191-16-098979:1
18,750 sharesCommon StockSEC:0001209191-16-098979:0
1,900 sharesCommon StockSEC:0001209191-16-095879:0
1,900 sharesCommon StockSEC:0001209191-16-095879:1
9,000 sharesCommon StockSEC:0001209191-16-095525:0
2,499 sharesCommon StockSEC:0001209191-16-095525:1
4,938 sharesCommon StockSEC:0001209191-16-095525:2
1,410 sharesCommon StockSEC:0001209191-16-095525:3
153 sharesCommon StockSEC:0001209191-16-095525:4
8,100 sharesCommon StockSEC:0001209191-16-094259:0
2,500 sharesCommon StockSEC:0001209191-16-094259:1
2,700 sharesCommon StockSEC:0001209191-16-094259:2
2,800 sharesCommon StockSEC:0001209191-16-094259:3
100 sharesCommon StockSEC:0001209191-16-094259:4
5,500 sharesCommon StockSEC:0001209191-16-092245:0
645 sharesCommon StockSEC:0001209191-16-092245:1
264 sharesCommon StockSEC:0001209191-16-092245:2
700 sharesCommon StockSEC:0001209191-16-092245:3
3,527 sharesCommon StockSEC:0001209191-16-092245:4
1,054 sharesCommon StockSEC:0001209191-16-092245:5
645 sharesCommon StockSEC:0001209191-16-092246:2
3,166 sharesCommon StockSEC:0001209191-16-092246:3
1,918 sharesCommon StockSEC:0001209191-16-092246:4
800 sharesCommon StockSEC:0001209191-16-092246:5
2,767 sharesCommon StockSEC:0001209191-16-092246:6
25 of 46 declarations
About Kite Pharma, Inc.
Kite Pharma, Inc. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It is listed on the NASDAQ under the ticker symbol KITE.